Saptagir Laboratories

Saptagir Laboratories is an Indian pharmaceutical manufacturing company focused on small-molecule active pharmaceutical ingredients, niche intermediates, and CDMO/CRAMS services. The company operates as part of the Saptagir Group and markets itself as a WHO-GMP-certified supplier serving customers in more than 20 countries. Its commercial portfolio includes APIs such as terbinafine hydrochloride, ezetimibe, camphor, solifenacin succinate, prasugrel hydrochloride, triclabendazole, and isoniazid, with additional products under development including tafamidis meglumine, edoxaban, and lasmiditan. Saptagir also provides process development, route scouting, scale-up, regulatory documentation support, and commercial manufacturing for key starting materials, advanced intermediates, and final APIs. The business appears to be a specialty pharma manufacturing and development partner rather than a novel-drug biotech company with proprietary clinical assets.